Russell Beckerman

Russell Beckerman serves as Integrated Innovation Associate, Office of the CEO at Alloy Therapeutics, Inc.. Alloy Therapeutics, Inc. operates in the research sector with approximately 140.0 employees. The company is headquartered in Cambridge, Massachusetts. Alloy Therapeutics, Inc. generates annual revenue of 10000000.0. To date, Alloy Therapeutics, Inc. has raised 182000000.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 3 executives at Alloy Therapeutics, Inc..
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Salesforce Cloudflare DNS SendInBlue Gmail Google Apps CloudFlare Hosting WP Engine OneTrust Braze Remote

biologics discovery drug discovery monoclonal antibodies bispecific antibodies tcr rna aso chimeric antigen receptors immunotherapy humanized transgenic mouse biotechnology biotech venture studios company creation biotechnology research biologics antibodies tcrs genetic medicine transgenic mice therapeutic antibodies biologics discovery services vaccine development partner collaboration bespoke discovery campaigns biopharmaceutical technologies pre-competitive technologies aso discovery anticlastic asos machine learning ai-driven antibody discovery high-throughput screening cd3 bispecifics car-t engineering peptide therapeutics cell therapies humanized transgenic mice affinity maturation biologics platforms platform licensing clinical development functional testing early drug discovery cancer therapies oncology drug delivery viral vector systems rna therapy clinical validation drug target discovery antibody humanization molecular biology phage display technology genomics antibody engineering lead identification alloys platform biologic modalities disease treatment immune response enhancement cross-reactivity analysis epitope mapping therapeutic index improvement biologics drug discovery antibody optimization t-cell receptors genetic medicines peptides cell therapy advanced biologics platforms customizable services innovation collaboration accessibility therapeutic development academic partnerships pharmaceutical collaborations drug discovery technologies hyperimmune strains ai/ml design functional assays democratizing access target-rich biotech pharmaceutical companies research organizations scientists drug developers therapeutic modalities collaborative ecosystem impactful medical breakthroughs artificial intelligence information technology & services hospital & health care

KC

Kelsey Cardenas Associate Director, Office of the CEO at Alloy Therapeutics, Inc.

RS

Richard Shimkets SVP Genetics and New Technologies and CEO, Daedamab at Alloy Therapeutics, Inc.

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

How can I contact Russell Beckerman?

Russell Beckerman's verified email address is available on MessageCEO. They currently work at Alloy Therapeutics, Inc.. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Russell Beckerman lead?

Russell Beckerman is Integrated Innovation Associate, Office of the CEO at Alloy Therapeutics, Inc., a company in the research sector with 140.0 employees. The company is based in Cambridge, Massachusetts.

What industry is Russell Beckerman in?

Russell Beckerman works in the research industry as Integrated Innovation Associate, Office of the CEO at Alloy Therapeutics, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Russell Beckerman's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Russell Beckerman's profile is kept up-to-date with the latest available information.

Last updated: April 8, 2026